Intraventricular Fibrinolysis for Aneurysmal Subarachnoid Haemorrhage: A Randomized Trial and Individual Patient Data Meta-analysis

Authors:

Abstract
Purpose: Aneurysmal subarachnoid haemorrhage (aSAH) is a severe form of stroke. Clearing blood from the cerebrospinal fluid by intraventricular fibrinolysis (IVF) through an external ventricular drain (EVD) has been hypothesized to improve functional outcome. The aim of this study was to evaluate the effect of IVF on functional outcome after aSAH. Methods: FIVHeMA is a multicentre phase III randomized controlled trial (RCT). Patients with aSAH requiring EVD insertion were included. Patients were randomized to receive either EVD alone or IVF. The primary outcome was good functional outcome at 6 months, defined as modified Rankin Scale (mRS) 0–3. To increase statistical power, an individual patient data meta-analysis (IPD-MA) of similar RCT was also performed. Results: The trial was terminated early because the target enrolment of 440 participants was deemed not feasible. 84 patients were randomized: 44 to EVD alone and 40 to IVF. Primary outcome was achieved in 39/44 (89%) with EVD alone and 34/40 (85%) with IVF (OR=0.7, 95% CI 0.2–2.6; p=0.63). Secondary and safety outcomes were similar across groups. Non-significant reductions were observed in delayed neurological deficit (OR=0.4, 95% CI 0.1–1.1; p=0.065) and chronic hydrocephalus (OR=0.4, 95% CI 0.1–1.0; p=0.054) in the IVF group. In the IPD-MA combining 137 patients from 4 trials, good outcome was observed in 55/71 (77%) with IVF and 50/66 (76%) with EVD alone (Peto OR=1.4, 95% CI 0.6–3.3; p=0.42).Conclusions: This prematurely terminated trial, complemented by IPD-MA, found no evidence that IVF improves functional outcome after aSAH.